№ files_lp_4_process_2_57730
File format: docx Character count: 6979 File size: 152 KB
Supplementary information for a clinical study on the effects of MARS therapy compared to standard medical treatment in patients with acute-on-chronic liver failure, including patient characteristics, organ failure assessment, and survival outcomes.
Year: 2026
Study type: Clinical research
Patient population: Adults with acute-on-chronic liver failure
Treatment evaluated: MARS therapy versus standard medical therapy (SMT)
Institutions: Multiple European hepatology centers
Authors: Hans U. Gerth, Michele Pohlen, Gerold Thölking, Hermann Pavenstädt, Marcus Brand, Anna Hüsing-Kabar, Christian Wilms, Miriam Maschmeier, Iyad Kabar, Marco Pavesi, Vicente Arroyo, Rafael Banares, Hartmut H. J. Schmidt
Sample size: 257 patients (Muenster cohort: 101; RELIEF cohort: 156)
Primary endpoints: 14-day and 28-day mortality
Secondary endpoints: Organ failure progression, transplant-free survival
Methods: CLIF-C organ failure scoring, hemodialysis, laboratory monitoring, infection screening, supportive care for cirrhosis complications
Follow-up period: Up to 28 days post-treatment
Data analysis: Survival analysis, recursive partitioning, subgroup comparisons
Document type: Supplementary material for a peer-reviewed journal article
Clinical context: Acute-on-chronic liver failure management and outcomes
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Asian Pacific Association for the Study of the Liver Consensus Recommendations on Hepatocellular Carcinoma-2010APASL Consensus Statements and Management Algorithms for Hepatitis C Virus Infection-2012Asian-Pacific Consensus statement on the management of chronic hepatitis B: A 2012 update-2012Acute-on-chronic liver failure: An Update on Consensus Recommendations of the Asian Pacific Association for the Study of the Liver (APASL)-2014ASIAN-PACIFIC CLINICAL PRACTICE GUIDELINES ON THE MANAGEMENT OF HEPATITIS B: A 2015 UPDATE-2015APASL consensus statements and recommendation on treatment of hepatitis C-2016APASL consensus statements and recommendations for hepatitis C prevention, epidemiology and laboratory testing-2016ASIAN-PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER (APASL) CONSENSUS GUIDELINES ON INVASIVE AND NON-INVASIVE ASSESSMENT OF HEPATIC FIBROSIS: A 2016 UPDA-2016Asia-Pacific clinical practice guideline on the management of hepatocellular carcinoma: a 2016 update-2017APASL clinical practice recommendation: How to treat HCV-infected patients with renal impairment?-2018APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation-2019ACUTE-ON-CHRONIC LIVER FAILURE: CONSENSUS RECOMMENDATIONS OF THE ASIAN PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER (APASL), AN UPDATE-2019The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver diseases-2020Asia-Pacific Association for the Study of the Liver Clinical Practice Guidance: The diagnosis and management of patients with autoimmune hepatitis-2021Budd-Chiari Syndrome: Consensus Guidelines of the Asian Pacific Association for the Study of the Liver (APASL)-2021APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy-2021APASL Clinical Practice Guidance: The diagnosis and management of patients with primary biliary cholangitis-2021APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients-2021Asian Pacific Association for the Study of Liver (APASL) Guidelines: Hepatitis B Virus in Pregnancy-2021Drug-Induced Liver Injury: Asia Pacific Association of Study of Liver Consensus Guidelines-2021Asian Pacific Association for the Study of the Liver Clinical Practice Guidelines on Liver Transplantation-2023Clinical Practice Guidelines on Haemochromatosis: Asian Pacific Association for the Study of the Liver-2023Asia Pacific Association for Study of Liver Guidelines on Management of Ascites in Liver Disease-2023APASL clinical practice guideline on systemic therapy for hepatocellular carcinoma-2024-2024Non-cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and management-2024The Asian Pacific Association for the Study of the Liver clinical practice guideline for the diagnosis and management of metabolic dysfunction-associated fatty liver disease-2024APASL CLINICAL PRACTICE GUIDELINES ON THE MANAGEMENT OF ACUTE KIDNEY INJURY IN ACUTE-ON-CHRONIC LIVER FAILURE-2024Acute-on-chronic liver failure (ACLF) - The ‘Kyoto Consensus’: Steps from Asia-2024
Year: 2010-2024
Region / city: Asia-Pacific
Subject: Hepatology
Document Type: Clinical Practice Guidelines
Organization / Institution: Asian Pacific Association for the Study of the Liver (APASL)
Author: APASL
Target Audience: Healthcare professionals
Period of validity: 2010-2024
Date of approval: 2010
Date of revisions: 2024
Context: Collection of clinical practice guidelines and consensus statements issued by the Asian Pacific Association for the Study of the Liver on various hepatological conditions, including hepatocellular carcinoma, hepatitis B and C, liver transplantation, and metabolic diseases.
Eco-Friendly Activated Eggshell Adsorbent for Acid Red 87 Dye Removal: A Kinetic Studies
Year: 2023
Region / City: Otuoke, Ogbia LGA, Bayelsa State, Nigeria
Theme: Environmental Remediation, Wastewater Treatment
Document Type: Research Paper
Institution: Federal University Otuoke
Author: Not specified
Target Audience: Researchers, Environmental Scientists
Period of Action: Not specified
Approval Date: Not specified
Date of Changes: Not specified
Topics: Recirculating ACUTE-ON-CHRONIC Adsorbent